TITLE: Recognizing November 8, 2025, as Premenstrual Dysphoric Disorder Awareness Day.

SUMMARY: Recognizing November 8, 2025, as Premenstrual Dysphoric Disorder Awareness Day.

FULL TEXT:
WHEREAS, The observance of Premenstrual Dysphoric Disorder Awareness Day on November 8, 2025, provides a fitting opportunity to rally support for women living with the condition; and WHEREAS, Premenstrual Dysphoric Disorder is a cyclical hormone-based mood disorder with mental, emotional, and physical symptoms that arise each month during the premenstrual phase of the menstrual cycle; PMDD presents itself one to two weeks before an individual begins menstruating, and symptoms may include mood swings, irritability, depression, difficulty focusing, sensitivity to rejection, changes in appetite, and muscle pain; typically, the disorder is diagnosed by tracking symptoms on a daily basis for two or more menstrual cycles; and WHEREAS, PMDD symptoms can significantly disrupt daily life and exacerbate mental health issues; many women with PMDD report experiencing suicidal thoughts during symptomatic times, and the disorder has led to higher rates of attempted suicide and self-harm; individuals experiencing the disorder may suffer from frequently missed workdays, reduced productivity, strained relationships, career disruption, educational setbacks, and financial stress from ongoing health care needs; and WHEREAS, An estimated 115 million women around the globe are affected by PMDD; like most menstrual disorders, PMDD diagnoses are very rare and research on the disorder is extremely limited; although PMDD affects up to five percent of women of childbearing age in the United States, over half of people with the disorder experience misdiagnoses or dismissals from providers; due to stigma surrounding mental health and menstruation, people with PMDD often suffer in silence and delay care, which increases the risk of negative outcomes; currently, there are no cures for the disorder, and it is most commonly managed by the prescription of oral contraceptives and antidepressant medications as well as through lifestyle choices; and WHEREAS, PMDD is a serious and life-changing health issue, and the observance of Premenstrual Dysphoric Disorder Awareness Day serves as a means of educating the public and promoting further research on menstrual and hormone-related mood disorders; now, therefore, be it RESOLVED, That the House of Representatives of the 89th Texas Legislature hereby recognize November 8, 2025, as Premenstrual Dysphoric Disorder Awareness Day and encourage all Texans to learn more about PMDD. Howard Speaker of the House I certify that H.R. No. 1298 was adopted by the House on May 29, 2025, by a non-record vote. Chief Clerk of the House